What Researchers Did
Researchers engineered a modified hemoprotein, RcoM-HBD-CCC, to act as a highly selective carbon monoxide scavenger for potential use as an antidote.
What They Found
They found that the engineered RcoM-HBD-CCC exhibited a high carbon monoxide affinity (Kd = 1.3 nM) and was 100-fold more selective for CO over oxygen. In a rat model, this scavenger rapidly reversed CO-induced cardiac dysfunction without causing a hypertensive effect.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor does it involve Canadian researchers or patient populations.
Study Limitations
A limitation of this study is that the findings are based on in vitro experiments and a rat model, requiring further human clinical trials to confirm efficacy and safety.